Stock listing
BOATS:BNTC Benitec Biopharma Inc. Stock
US listing (BOATS) of Benitec Biopharma Inc. · home listing NASDAQ:BNTC
Follow Benitec Biopharma Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BNTC
$8.49 USD -0.25 (-2.9%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BNTC
- Day range
- $8.24 – $8.94 USDNov 2, 2026
- Volume
- 240,632 sharesNov 2, 2026
- Market cap
- $296.2M USDAt the close on Nov 2, 2026 · price × 34.89M shares outstanding
- 52-week range
- $8.00 – $16.31 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.91M USDMedian day 138,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BNTC · Home | $8.49 USD | -0.25 (-2.9%) | 240,632 | $8.81 | $8.94 | $8.24 | $8.74 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:BNTC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.49 | -0.25 | -2.9% | $8.81 | $8.94 | $8.24 | 240,632 | |
| $8.74 | -0.09 | -1.0% | $8.80 | $8.93 | $8.429 | 135,485 | |
| $8.83 | +0.03 | +0.3% | $8.85 | $9.11 | $8.73 | 162,538 | |
| $8.80 | +0.12 | +1.4% | $8.58 | $8.91 | $8.19 | 238,599 | |
| $8.68 | +0.09 | +1.0% | $8.60 | $8.849 | $8.52 | 156,893 | |
| $8.59 | -0.06 | -0.7% | $8.71 | $8.80 | $8.54 | 98,628 | |
| $8.65 | -0.17 | -1.9% | $8.91 | $8.91 | $8.53 | 158,391 | |
| $8.82 | +0.32 | +3.8% | $8.47 | $8.85 | $8.21 | 149,010 | |
| $8.50 | -0.54 | -6.0% | $9.05 | $9.22 | $8.40 | 171,850 | |
| $9.04 | +0.68 | +8.1% | $8.35 | $9.29 | $8.32 | 347,596 | |
| $8.36 | +0.25 | +3.1% | $8.13 | $8.618 | $8.00 | 194,120 | |
| $8.11 | -0.35 | -4.1% | $8.47 | $8.47 | $8.06 | 158,600 | |
| $8.46 | +0.17 | +2.1% | $8.37 | $8.758 | $8.34 | 153,700 | |
| $8.29 | -0.34 | -3.9% | $8.52 | $9.07 | $8.25 | 162,500 | |
| $8.63 | -0.44 | -4.9% | $9.08 | $9.08 | $8.51 | 151,400 | |
| $9.07 | +0.20 | +2.3% | $8.90 | $9.25 | $8.75 | 200,900 | |
| $8.87 | +0.12 | +1.4% | $8.72 | $9.03 | $8.71 | 73,000 | |
| $8.75 | -0.24 | -2.7% | $8.86 | $8.97 | $8.61 | 234,900 | |
| $8.99 | -0.01 | -0.1% | $8.81 | $9.27 | $8.80 | 190,100 | |
| $9.00 | -0.23 | -2.5% | $9.32 | $9.565 | $8.62 | 217,200 | |
| $9.23 | +0.25 | +2.8% | $9.00 | $9.99 | $8.52 | 584,200 | |
| $8.98 | -0.60 | -6.3% | $9.71 | $9.876 | $8.92 | 135,100 | |
| $9.58 | -0.42 | -4.2% | $9.94 | $10.17 | $9.465 | 103,100 | |
| $10.00 | +0.25 | +2.6% | $9.83 | $10.13 | $9.64 | 146,000 | |
| $9.75 | -0.27 | -2.7% | $10.17 | $10.17 | $9.65 | 111,000 | |
| $10.02 | +0.43 | +4.5% | $9.57 | $10.04 | $9.31 | 152,800 | |
| $9.59 | -0.05 | -0.5% | $9.70 | $9.80 | $9.306 | 107,000 | |
| $9.64 | -0.19 | -1.9% | $9.74 | $10.41 | $9.255 | 196,700 | |
| $9.83 | -1.12 | -10.2% | $10.92 | $11.32 | $9.49 | 644,200 | |
| $10.95 | +0.07 | +0.6% | $10.97 | $11.37 | $10.61 | 88,900 | |
| $10.88 | -0.14 | -1.3% | $11.12 | $11.14 | $10.74 | 121,900 | |
| $11.02 | -0.34 | -3.0% | $11.37 | $11.62 | $10.86 | 423,000 | |
| $11.36 | +0.32 | +2.9% | $11.27 | $11.55 | $11.15 | 91,300 | |
| $11.04 | -0.01 | -0.1% | $11.09 | $11.45 | $10.89 | 138,800 | |
| $11.05 | -1.03 | -8.5% | $12.11 | $12.37 | $10.96 | 263,400 | |
| $12.08 | -0.11 | -0.9% | $12.24 | $12.42 | $12.01 | 106,400 | |
| $12.19 | -0.03 | -0.2% | $12.38 | $12.51 | $12.12 | 88,600 | |
| $12.22 | -0.23 | -1.8% | $12.31 | $12.47 | $12.00 | 94,600 | |
| $12.45 | -0.275 | -2.2% | $12.68 | $13.00 | $12.22 | 70,000 | |
| $12.73 | +0.045 | +0.4% | $12.55 | $13.00 | $12.51 | 102,200 | |
| $12.68 | +0.24 | +1.9% | $12.33 | $12.83 | $12.33 | 45,000 | |
| $12.44 | -0.44 | -3.4% | $12.93 | $13.28 | $12.24 | 62,600 | |
| $12.88 | +0.57 | +4.6% | $12.36 | $13.19 | $12.25 | 191,400 | |
| $12.31 | +0.14 | +1.2% | $12.12 | $12.43 | $11.80 | 78,300 | |
| $12.17 | -0.30 | -2.4% | $12.37 | $12.57 | $12.01 | 60,800 | |
| $12.47 | -0.20 | -1.6% | $12.60 | $12.76 | $11.71 | 103,200 | |
| $12.67 | -0.21 | -1.6% | $13.20 | $13.21 | $12.60 | 103,200 | |
| $12.88 | -0.14 | -1.1% | $13.02 | $13.02 | $12.65 | 64,600 | |
| $13.02 | +0.31 | +2.4% | $12.79 | $13.35 | $12.76 | 255,000 | |
| $12.71 | -0.77 | -5.7% | $13.53 | $13.64 | $12.47 | 122,500 | |
| $13.48 | +0.47 | +3.6% | $13.14 | $13.98 | $13.03 | 160,100 | |
| $13.01 | -0.37 | -2.8% | $13.27 | $13.27 | $12.37 | 426,800 | |
| $13.38 | +0.50 | +3.9% | $13.13 | $13.47 | $12.78 | 138,000 | |
| $12.88 | -0.19 | -1.5% | $13.07 | $13.65 | $12.43 | 211,200 | |
| $13.07 | +0.51 | +4.1% | $12.52 | $13.19 | $11.89 | 81,400 | |
| $12.56 | 0.00 | 0.0% | $12.54 | $12.67 | $12.21 | 169,000 | |
| $12.56 | +0.22 | +1.8% | $12.40 | $12.97 | $12.40 | 164,500 | |
| $12.34 | -1.14 | -8.5% | $13.57 | $13.79 | $12.24 | 1,268,600 | |
| $13.48 | -0.30 | -2.2% | $13.86 | $13.96 | $13.23 | 53,600 | |
| $13.78 | +0.15 | +1.1% | $13.53 | $13.95 | $13.32 | 89,000 | |
| $13.63 | +0.50 | +3.8% | $13.26 | $13.75 | $13.07 | 41,100 | |
| $13.13 | +0.44 | +3.5% | $12.71 | $13.33 | $12.71 | 82,900 | |
| $12.69 | +0.17 | +1.4% | $12.78 | $12.88 | $12.19 | 95,200 | |
| $12.52 | +0.37 | +3.0% | $12.29 | $12.83 | $12.17 | 64,800 | |
| $12.15 | +0.44 | +3.8% | $11.87 | $12.24 | $11.50 | 102,000 |
- Ticker
- BOATS:BNTC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
Latest deck · May 15, 2026
American Society of Cell & Gene Therapy 2026
Conference · 20 slides
Latest news
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
Oct 28, 2026
Closed $8.80 (+1.4%) on Oct 28, 2026
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
Oct 5, 2026
Closed $9.23 (+2.8%) on Oct 5, 2026
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Sep 14, 2026
Closed $11.05 (-8.5%) on Sep 15, 2026
Unleash Your Ultimate Kaiju! Godziburst and Godzilla Scramble Figures Available for Pre-Order Starting June 25
Jun 25, 2026
Closed $13.00 (-4.6%) on Jun 25, 2026
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
May 14, 2026
Closed $11.85 (+1.7%) on May 14, 2026
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Apr 28, 2026
Closed $12.17 (-3.5%) on Apr 28, 2026
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development fo...
Mar 10, 2026
Closed $12.27 (-2.2%) on Mar 10, 2026
Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Mar 9, 2026
Closed $12.55 (+10.7%) on Mar 9, 2026
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
Feb 23, 2026
Closed $10.72 (+0.8%) on Feb 23, 2026
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
Feb 12, 2026
Closed $11.34 (-2.7%) on Feb 12, 2026
Decks
American Society of Cell & Gene Therapy 2026
Conference · 20 slides · May 15, 2026
Investor Presentation (January 2026)
Investor deck · 43 slides · January 2026
Corporate Update (November 2025)
Corporate update · 31 slides · Nov 3, 2025
Investor Presentation (September 2025)
Investor deck · 34 slides · September 2025
Benitec Biopharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 83 in all · newest Oct 28, 2026 · oldest 2019
- Decks
- 39 decks · latest May 15, 2026
Where Benitec Biopharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BNTC · Home listing | NASDAQ | United States | USD |
| BOATS:BNTC · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Benitec Biopharma Inc.